We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months

News   Sep 25, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months
 
 
Advertisement
 

RELATED ARTICLES

Your Cells Look Young for Their Age, Compared to a Chimp's

News

Part of the secret to human longevity, researchers say, may lie in chemical changes along the DNA within our cells that slowed the rate of human aging in the 7 to 8 million years since our ancestors went their separate ways from chimps.

READ MORE

Smart Cells Developed With Potential To Treat Illness at the Cellular Level

News

New research by an international team of chemists describes a new type of artificial cell that can communicate with other cells within the body--with potential applications in the field of smart pharmaceuticals.

READ MORE

Study Finds THC Can Help Prevent Colon Cancer in Mice

News

Tetrahydrocannabinol (THC) may be able to prevent the development of colon cancers, say researchers from the University of South Carolina.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE